Expanding the Clinicopathologic Spectrum of YAP1::MAML2-Rearranged Thymic Neoplasm

Mod Pathol. 2023 Feb;36(2):100048. doi: 10.1016/j.modpat.2022.100048. Epub 2023 Jan 11.

Authors

Eric Eunshik Kim¹, Ye Yoon Suh¹, Sang Won Lee¹, Jeong Mo Bae¹, Kyoungbun Lee¹, Sungyoung Lee², Hongseok Yun², Kyeong Cheon Jung¹, Jiwon Koh³

Affiliations

¹ Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
² Department of Genomic Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
³ Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: jwskoh@snu.ac.kr.

PMID: 36853792
DOI: 10.1016/j.modpat.2022.100048

No abstract available

Keywords: carcinosarcoma; fusion; metaplastic thymoma; mutation.

Publication types

Letter

MeSH terms

Humans
Neoplasms*
Trans-Activators

Substances

MAML2 protein, human
Trans-Activators